º¬Ð߲ݴ«Ã½

Quarterly report pursuant to Section 13 or 15(d)

Stock-Based Compensation (Tables)

v3.22.2.2
Stock-Based Compensation (Tables)
 9 Months Ended
Sep. 30, 2022
Schedule of number and weighted average GDFV of option granted

​

​

​

​

​

​

​

​

​

​

Nine months ended

​

​

​

SeptemberÌý30, 2022

​

​

​

RSUs Granted (000's)

​

Weighted Average GDFV

​

​

​

​

​

​

​

​

Series A º¬Ð߲ݴ«Ã½ common stock, subsidiary employees (1)

​

11,101

​

$

4.82

​

Series A º¬Ð߲ݴ«Ã½ common stock, º¬Ð߲ݴ«Ã½ employees and directors (2)

​

217

​

$

4.91

​

Series A º¬Ð߲ݴ«Ã½ common stock, º¬Ð߲ݴ«Ã½ President and CEO (3)

​

596

​

$

4.91

​

Series B º¬Ð߲ݴ«Ã½ common stock, º¬Ð߲ݴ«Ã½ Chairman of the Board (4)

​

327

​

$

4.95

​
(1) Grants mainly vest equally over three years.
(2) Grants mainly vest one year from the month of grant, subject to the satisfaction of certain performance objectives.
(3) Grant vests one year from the month of grant, subject to the satisfaction of certain performance objectives. Grant was made in connection with the employment agreement of our President and Chief Executive Officer.
(4) Grant vests one year from the month of grant, subject to the satisfaction of certain performance objectives. Grant was made in connection with our Chairman’s employment agreement. Ìý
Schedule of number and weighted average GDFV of RSUs granted to certain officers, employees and directors

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Weighted

​

​

​

Weighted

​

​

​

³§±ð°ù¾±±ð²õÌý´¡

​

Average

​

³§±ð°ù¾±±ð²õÌýµþ

​

Average

​

​

​

(000's)

​

GDFV

​

(000's)

​

GDFV

​

RSUs outstanding at January 1, 2022

Ìý

12,905

​

$

9.38

​

—

​

$

—

​

Granted

Ìý

11,914

​

$

4.83

​

327

​

$

4.95

​

Vested

Ìý

(3,859)

​

$

10.02

​

—

​

$

—

​

Forfeited/Cancelled

Ìý

(3,479)

​

$

7.54

​

—

​

$

—

​

RSUs outstanding at September 30, 2022

Ìý

17,481

​

$

6.50

​

327

​

$

4.95

Ìý
Common Class A Ìý
Schedule of number, weighted average exercise price ("WAEP"), Weighted average remaining life and aggregate intrinsic value of the awards

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

ÌýÌýÌýÌý

​

ÌýÌýÌýÌý

​

​

ÌýÌýÌýÌý

Weighted

ÌýÌýÌýÌý

Aggregate

Ìý

​

​

​

​

​

​

​

average

​

intrinsic

​

​

​

³§±ð°ù¾±±ð²õÌý´¡

​

​

​

​

remaining

​

value

​

​

​

(000's)

​

WAEP

​

life

​

(millions)

​

Options outstanding at January 1, 2022

Ìý

42,110

​

$

9.23

​

​

​

​

​

​

​

Granted

Ìý

—

​

$

—

​

​

​

​

​

​

​

Exercised

Ìý

(392)

​

$

2.26

​

​

​

​

​

​

​

Forfeited/Cancelled

Ìý

(4,705)

​

$

10.70

​

​

​

​

​

​

​

Options outstanding at SeptemberÌý30, 2022

Ìý

37,013

​

$

9.12

Ìý

2.8

years

​

$

—

​

Options exercisable at SeptemberÌý30, 2022

Ìý

25,260

​

$

10.81

Ìý

2.0

years

​

$

—

​
Common Class B Ìý
Schedule of number, weighted average exercise price ("WAEP"), Weighted average remaining life and aggregate intrinsic value of the awards

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

ÌýÌýÌýÌý

​

ÌýÌýÌýÌý

​

​

ÌýÌýÌýÌý

Weighted

ÌýÌýÌýÌý

Aggregate

Ìý

​

​

​

​

​

​

​

average

​

intrinsic

​

​

​

³§±ð°ù¾±±ð²õÌýµþ

​

​

​

​

remaining

​

value

​

​

​

(000's)

​

WAEP

​

life

​

(millions)

​

Options outstanding at January 1, 2022

Ìý

2,221

​

$

12.25

​

​

​

​

​

​

​

Granted

Ìý

—

​

$

—

​

​

​

​

​

​

​

Exercised

Ìý

—

​

$

—

​

​

​

​

​

​

​

Forfeited/Cancelled

​

—

​

$

—

​

​

​

​

​

​

​

Options outstanding at SeptemberÌý30, 2022

Ìý

2,221

​

$

12.25

Ìý

1.0

year

​

$

—

​

Options exercisable at SeptemberÌý30, 2022

Ìý

2,221

​

$

12.25

Ìý

1.0

year

​

$

—

​